Ketamine

Generic Name
Ketamine
Brand Names
Ketalar
Drug Type
Small Molecule
Chemical Formula
C13H16ClNO
CAS Number
6740-88-1
Unique Ingredient Identifier
690G0D6V8H
Background

Ketamine is an NMDA receptor antagonist with a potent anesthetic effect. It was developed in 1963 as a replacement for phencyclidine (PCP) by Calvin Stevens at Parke Davis Laboratories. It started being used for veterinary purposes in Belgium and in 1964 was proven that compared to PCP, it produced minor hallucinogenic effects and shorter psychotomimetic eff...

Indication

Ketamine is indicated as an anesthetic agent for recommended diagnostic and surgical procedures. If skeletal muscle relaxation is needed, it should be combined with a muscle relaxant. If the surgical procedure involves visceral pain, it should be supplemented with an agent that obtunds visceral pain. Ketamine can be used for induction of anesthesia prior oth...

Associated Conditions
-
Associated Therapies
General Anesthesia, Induction and Maintenance of General Anesthesia

A Blinded, Four-Way Crossover in Healthy Subjects to Assess EEG After Administration of Ketamine, Placebo and AZD6765

Phase 1
Terminated
Conditions
Interventions
First Posted Date
2010-05-26
Last Posted Date
2014-10-13
Lead Sponsor
AstraZeneca
Target Recruit Count
36
Registration Number
NCT01130909
Locations
🇫🇷

Research Site, Rouffach, France

Combined Ketamine/Propofol for Emergency Department Procedural Sedation

First Posted Date
2010-05-20
Last Posted Date
2023-04-24
Lead Sponsor
University of Missouri-Columbia
Target Recruit Count
107
Registration Number
NCT01126957
Locations
🇺🇸

University of Missouri - Columbia dept. of Emergency Medicine, Columbia, Missouri, United States

Ketamine Challenge Study With JNJ-40411813

First Posted Date
2010-04-12
Last Posted Date
2014-04-08
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
40
Registration Number
NCT01101659

Immunomodulatory Properties of Ketamine in Sepsis

Phase 1
Completed
Conditions
Interventions
First Posted Date
2010-03-18
Last Posted Date
2017-08-21
Lead Sponsor
Beth Israel Deaconess Medical Center
Target Recruit Count
19
Registration Number
NCT01089361
Locations
🇺🇸

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Escalating Ketamine Doses and Pre-emption

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2010-02-17
Last Posted Date
2010-02-17
Lead Sponsor
Tel-Aviv Sourasky Medical Center
Target Recruit Count
120
Registration Number
NCT01070108
Locations
🇮🇱

Tel Aviv Medical Center, Tel Aviv, Israel

A Comparison of Ketofol (Ketamine and Propofol Admixture) Versus Propofol as Induction Agents on Hemodynamic Parameters

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2010-02-09
Last Posted Date
2013-05-03
Lead Sponsor
Mayo Clinic
Target Recruit Count
85
Registration Number
NCT01065350
Locations
🇺🇸

Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States

Study Where Pharmaco Magnetic Resonance Imaging (MRI) Effects of AZD6765 Will be Compared to Placebo in Depressive Male and Female Subjects

Phase 1
Completed
Conditions
Interventions
First Posted Date
2010-01-12
Last Posted Date
2014-10-13
Lead Sponsor
AstraZeneca
Target Recruit Count
128
Registration Number
NCT01046630
Locations
🇬🇧

Research Site, Oxford, United Kingdom

Preemptive Low-dose Epidural Ketamine for Preventing Chronic Post-thoracotomy Pain

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2009-11-20
Last Posted Date
2009-11-20
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
209
Registration Number
NCT01017393
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

Dexmedetomidine Sedation With Third Molar Surgery

Phase 4
Terminated
Conditions
Interventions
First Posted Date
2009-11-20
Last Posted Date
2013-06-17
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
18
Registration Number
NCT01017237
Locations
🇺🇸

University of North Carolina School of Dentistry, Chapel Hill, North Carolina, United States

Propofol Versus Ketamine for Moderate Procedural Sedation in the Emergency Department (ED)

Phase 4
Completed
Conditions
Interventions
First Posted Date
2009-10-19
Last Posted Date
2012-04-02
Lead Sponsor
Hennepin Healthcare Research Institute
Target Recruit Count
100
Registration Number
NCT00997321
Locations
🇺🇸

Hennepin County Medical Center, Minneapolis, Minnesota, United States

© Copyright 2024. All Rights Reserved by MedPath